These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6509795)

  • 21. Prostaglandin synthesis and release by subpopulations of rat alveolar macrophages.
    Chandler DB; Fulmer JD
    J Immunol; 1987 Aug; 139(3):893-8. PubMed ID: 3110287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation.
    Taramelli D; Holden HT; Varesio L
    J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macrophage activation to kill Leishmania tropica: kinetics of macrophage response to lymphokines that induce antimicrobial activities against amastigotes.
    Oster CN; Nacy CA
    J Immunol; 1984 Mar; 132(3):1494-500. PubMed ID: 6363544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressor alveolar macrophages in experimentally induced uremia.
    Alevy YG; Hutcheson P; Mueller KR; Slavin RG
    J Reticuloendothel Soc; 1983 Jan; 33(1):11-20. PubMed ID: 6572723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alveolar macrophages. VI. Regulation of alveolar macrophage-mediated suppression of lymphocyte proliferation by a putative T cell.
    Warner LA; Holt PG; Mayrhofer G
    Immunology; 1981 Jan; 42(1):137-47. PubMed ID: 6970172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine release by macrophages after interacting with CSF-1 and extracellular matrix proteins: characteristics of a mouse model of inflammatory responses in vitro.
    Kremlev SG; Chapoval AI; Evans R
    Cell Immunol; 1998 Apr; 185(1):59-64. PubMed ID: 9636683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of interferon-gamma on cytotoxicity of murine activated macrophages against murine glioma cells].
    Ohyama K; Kikuchi H; Oda Y; Moritake K; Yamasaki T
    No To Shinkei; 1993 Jun; 45(6):525-30. PubMed ID: 8363848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis.
    Zhu XH; Zellweger R; Wichmann MW; Ayala A; Chaudry IH
    Cytokine; 1997 Jun; 9(6):437-46. PubMed ID: 9199878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
    Taramelli D; Varesio L
    J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage-mediated tumor cell killing: regulation of expression of cytolytic activity by prostaglandin E.
    Taffet SM; Russell SW
    J Immunol; 1981 Feb; 126(2):424-7. PubMed ID: 7451984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage antitumor activity in vitro. Comparative analysis of cytolytic, cytostatic, and cytotoxic activities of mouse macrophages and human monocytes.
    Soldateschi D; Censini S; de Gori V; Antoni G; Tagliabue A; Boraschi D
    Immunobiology; 1984 May; 166(3):251-62. PubMed ID: 6376332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced responsiveness of committed macrophage precursors to macrophage-type colony-stimulating factor (CSF-1) induced in vitro by interferons alpha + beta 1.
    Moore RN; Rouse BT
    J Immunol; 1983 Nov; 131(5):2374-8. PubMed ID: 6605386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible macrophage apoptosis following sepsis is mediated by cysteine protease activation and nitric oxide release.
    Williams TE; Ayala A; Chaudry IH
    J Surg Res; 1997 Jul; 70(2):113-8. PubMed ID: 9245558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The activation of tumoricidal properties in macrophages of endotoxin responder and nonresponder mice by liposome-encapsulated immunomodulators.
    Fogler WE; Talmadge JE; Fidler IJ
    J Reticuloendothel Soc; 1983 Mar; 33(3):165-74. PubMed ID: 6834360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of lymphokine-mediated activation of macrophages for antigen presentation: studies with long-term cultured bone marrow-derived macrophages and cloned T cells.
    Fischer HG; Reske-Kunz AB; Spaeth E; Kirchner H; Rüde E
    Immunobiology; 1984 Dec; 168(3-5):232-45. PubMed ID: 6442269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons.
    Boraschi D; Censini S; Bartalini M; Tagliabue A
    J Immunol; 1985 Jul; 135(1):502-5. PubMed ID: 3923110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the immunoregulatory functions of alveolar macrophages in cell-mediated immune responses.
    Igietseme JU; Herscowitz HB
    Reg Immunol; 1990; 3(1):46-55. PubMed ID: 2171621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E is required for the augmentation of procoagulant activity of LPS-stimulated rabbit alveolar macrophages.
    Sitrin RG; Kaltreider HB; Goldyne ME
    J Immunol; 1984 Feb; 132(2):867-71. PubMed ID: 6581228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro.
    Chen GH; Curtis JL; Mody CH; Christensen PJ; Armstrong LR; Toews GB
    J Immunol; 1994 Jan; 152(2):724-34. PubMed ID: 8283047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo regulation of macrophage IL-12 production during type 1 and type 2 cytokine-mediated granuloma formation.
    Chensue SW; Ruth JH; Warmington K; Lincoln P; Kunkel SL
    J Immunol; 1995 Oct; 155(7):3546-51. PubMed ID: 7561051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.